Using AI Chatbots to Help Diabetic Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the effectiveness of generative AI chatbots in assisting diabetic patients by providing them with accurate information on diet, stress management, and weight control. With diabetes affecting millions globally and leading to serious complications, the research aims to evaluate patient interactions with AI chatbots, both with and without human support. Specialists will assess these interactions, and patient feedback will be collected to understand their experiences and perceptions of the chatbot assistance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Present physically in Pakistan
* Adults (18 years or older)
* Diabetic Patient

Exclusion Criteria:

* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Prisoners

Where it's running

• CDLE, PCSIR Lbas Complex
  Karachi, Sindh, Pakistan Recruiting

Study contacts

• Principal investigator: Ghulam Mustafa — Pakistan Council of Scientific and Industrial Research
• Study coordinator: Ghulam Mustafa
• Email: mustafabme@gmail.com
• Phone: +923322340395

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ROME GS sensor comparison with Eversense 365 for continuous glucose monitoring

  This study will test whether the redesigned ROME GS glucose sensor is as safe and accurate as the Eversense 365 in adults with diabetes.

  Recruiting at 3 sites Senseonics, Inc. · Escondido, California and 3 other locations · NCT07518004

• Tracking retinal changes over two years in people with moderate to early proliferative diabetic retinopathy

  This project will try to find imaging, functional, and blood markers that show whether retinopathy is getting worse over two years in people with type 2 diabetes and moderate-to-mildly advanced disease.

  Recruiting Association for Innovation and Biomedical Research on Light and Image · Coimbra · NCT07458516

• Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes

  This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.

  Recruiting at 3 sites Steno Diabetes Center Copenhagen · Copenhagen and 2 other locations · NCT07250789

• iLet Bionic Pancreas started through primary care for adults on insulin

  This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.

  Recruiting University of Colorado, Denver · Aurora, Colorado and 1 other locations · NCT07011147

• Improving diagnosis and treatment of diabetic retinopathy in type 2 diabetes

  This study is testing a new way to spot and treat diabetic eye disease in people with type 2 diabetes by using a mix of health data and advanced technology to improve care.

  Recruiting at 3 sites Shanghai General Hospital, China · Lanzhou and 2 other locations · NCT06821399

• Remote ischemic conditioning to treat early diabetic retinopathy

  This trial will test whether remote ischemic conditioning — brief, repeated arm cuff inflations — helps adults aged 40–80 with mild-to-moderate non-proliferative diabetic retinopathy.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality and 1 other locations · NCT06713720

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.